Premium
Weight gain after orthotopic liver transplantation: Is nonalcoholic fatty liver disease cirrhosis a risk factor for greater weight gain?
Author(s) -
Kouz Jasmine,
Vincent Catherine,
Leong Aaron,
Dorais Marc,
Räkel Agnès
Publication year - 2014
Publication title -
liver transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.814
H-Index - 150
eISSN - 1527-6473
pISSN - 1527-6465
DOI - 10.1002/lt.23951
Subject(s) - medicine , nonalcoholic fatty liver disease , liver transplantation , body mass index , cirrhosis , gastroenterology , weight gain , transplantation , odds ratio , fatty liver , risk factor , ascites , confounding , overweight , surgery , disease , body weight
Posttransplant weight gain is common after orthotopic liver transplantation. We sought to determine the extent of weight gain at 5 years after transplantation in patients with nonalcoholic fatty liver disease (NAFLD) cirrhosis versus patients with other types of cirrhosis (non‐NAFLD). We studied 126 liver transplants performed between 2005 and 2007 at Saint Luc Hospital, University of Montreal. Seventeen of the 126 patients (13.5%) had NAFLD cirrhosis. Ascites volume was difficult to assess, so we used the body mass index (BMI) at 3 months as the reference BMI. All patients gained weight after transplantation, but BMI increased significantly more and earlier among the NAFLD patients [4.8 versus 1.5 kg/m 2 at 1 year ( P = 0.001), 5.0 versus 2.3 kg/m 2 at 2 years ( P = 0.01), and 5.6 versus 2.6 kg/m 2 at 5 years ( P = 0.009)] in comparison with non‐NAFLD patients in unadjusted analyses. The greatest BMI increase over time was investigated with univariate and multivariate logistic regression analyses. The BMI increase was divided into tertiles for each period of time observed. The greatest BMI increase over time was defined as the top tertile of BMI increase. After adjustments for potential confounders (ie, total cholesterol, diabetes, and length of hospital stay), NAFLD was no longer associated with a risk of a greater BMI increase [odds ratio (OR) = 3.73 at 1 year ( P = 0.11), OR = 2.15 at 2 years ( P = 0.34), and OR = 2.87 at 5 years ( P = 0.30)]. These findings suggest the need for multidisciplinary, early, and close weight monitoring for all patients. All patients could benefit from pretransplant counseling regarding weight gain and its consequences. Liver Transpl 20:1266‐1274, 2014 . © 2014 AASLD.